Institutional investors purchased a net $5.1 million shares of VTUS during the quarter ended December 2012 and now own 66.09% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
| Other institutional | 61.05% |
| Mutual fund holders | 5.04% |
| Individual stakeholders | 0.25% |